Cover Image

The FDA has Approved Bozutinib for Children with Chronic Myelogenous Leukemia

.

Saved in:

Bibliographic Details
Main Author:	article Editorial (Author)
Format:	Book
Published:	Union of pediatricians of Russia, 2023-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

FDA HAS APPROVED THE FIRST THERAPY FOR NEUROENDOCRINE TUMORS IN CHILDREN
by: article Editorial
Published: (2024)

FDA HAS APPROVED NEW DRUG TREATMENT FOR HIV IN CHILDREN
by: article Editorial
Published: (2024)

FDA Has Approved Evolocumab for Theatment of Familial Hypercholesterolemia in Children
by: article Editorial
Published: (2021)

The FDA has approved the first treatment for Friedreich's ataxia
by: article Editorial
Published: (2023)

THE FDA HAS APPROVED THE TRIPLE COMBINATION TOPICAL ACNE REMEDY
by: article Editorial
Published: (2023)

THE FDA HAS APPROVED THE FIRST VACCINE AGAINST THE CHIKUNGUNYA VIRUS
by: article Editorial
Published: (2023)

The FDA has approved the first medical drug for Rett syndrome
by: article Editorial
Published: (2023)

THE FDA HAS APPROVED DUPILUMAB FOR THE PEDIATRIC TREATMENT OF ESOPHAGEAL DISEASES
by: article Editorial
Published: (2024)

FDA HAS APPROVED THE LIQUID ADHD MEDICATION (NOT A STIMULANT)
by: article Editorial
Published: (2024)

FDA Has Approved First Drug for Treatment of Congenital Athymia
by: article Editorial
Published: (2021)

FDA Has Approved First Long-Acting Growth Hormone Preparation for Children
by: article Editorial
Published: (2021)

FDA HAS APPROVED NEW DRUG TREATMENT FOR DUCHENE MUSCULAR DYSTROPHY
by: article Editorial
Published: (2024)

FDA HAS APPROVED THE FIRST MEDICATION FOR RARE IMMUNITY-RELATED DISEASES
by: article Editorial
Published: (2024)

The FDA has approved the first gene therapy for the treatment of Duchennel's muscular dystrophy
by: article Editorial
Published: (2023)

THE FDA HAS APPROVED THE THE FIRST DRUG FOR THE CONGENITAL FORM OF THROMBOTIC THROMBOCYTOPENIC PURPURA
by: article Editorial
Published: (2023)

The FDA has approved the first medical drug for the treatment of primary immunodeficiency APDS
by: article Editorial
Published: (2023)

The FDA has approved a new drug for adolescents and adults with severe focal alopecia
by: article Editorial
Published: (2023)

FOR THE FIRST TIME, THE FDA HAS APPROVED A GEL FOR THE TREATMENT OF MOLLUSCUM CONTAGIOSUM AT HOME
by: article Editorial
Published: (2024)

THE FDA HAS APPROVED TWO GENE THERAPY DRUGS FOR THE TREATMENT OF SICKLE CELL ANEMIA
by: article Editorial
Published: (2024)

The FDA has approved a vaccine for the prevention of whooping cough in infants up to 2 months of life
by: article Editorial
Published: (2023)

FDA approves belimumab for treatment of children with lupus nephritis
by: article Editorial
Published: (2022)

FDA approved injection drug against schizophrenia
by: article Editorial
Published: (2023)

Occurrence of chronic lymphocytic leukemia in patients with chronic myelogenous leukemia
by: Pritish K Bhattacharyya
Published: (2013)

Supremacy of nanoparticles in the therapy of chronic myelogenous leukemia
by: Gopalarethinam Janani, et al.
Published: (2023)

FDA APPROVED A NEW DRUG FOR THE TREATMENT OF ATOPIC DERMATITIS
by: article Editorial
Published: (2024)

FDA APPROVED THE FIRST NASAL SPRAY WITH ADRENALINE TO ELIMINATE ANAPHYLAXIS
by: article Editorial
Published: (2024)

FDA HAS APPROVED NEW TREATMENT FOR CHILDREN WITH ANY HEPATITIS C VIRUS STRAINS
Published: (2020)

The treatment of pediatric chronic myelogenous leukemia in the imatinib era
by: Jae Wook Lee, et al.
Published: (2011)

Chronic lymphocytic leukemia developing in a case of chronic myelogenous leukemia: Some observations
by: Mayur Parihar, et al.
Published: (2014)

Chronic myelogenous leukemia in sickle cell/beta 0 -thalassemia
by: Maha M Sallam, et al.
Published: (2011)

FDA HAS ASSIGNED RMAT STATUS TO RETT SYNDROME GENE THERAPY
by: article Editorial
Published: (2024)

EUROPEAN COMMISSION HAS APPROVED NEW VACCINE TO PROTECT CHILDREN FROM PNEUMOCOCCAL INFECTION
by: article Editorial
Published: (2024)

The FDA has expanded the indications for the appointment of an oral janus kinase 1 inhibitor
by: article Editorial
Published: (2023)

A case of chronic myelogenous leukemia cutis: A rare presentation
by: U S Kanade, et al.
Published: (2011)

The role of Lyn kinase in the development of imatinib resistance in chronic myelogenous leukemia
by: Camillo Porta, et al.
Published: (2011)

Bilineage T-lymphoblastic/myeloid extramedullary blast crisis in chronic myelogenous leukemia
by: Indu M Nair, et al.
Published: (2016)

EMA HAS APPROVED MEDICATION FOR BLOOD CLOTTING AT FACTOR VIII DEFICIENCY
by: article Editorial
Published: (2024)

The drug for repletion of the lack of growth hormone has been approved in the United States
by: article Editorial
Published: (2023)

Cutaneous polyarteritis nodosa presenting as a paraneoplastic phenomenon in chronic myelogenous leukemia
by: Tesia C. Kolodziejczyk, BA, et al.
Published: (2021)

Sudden Sensorineural Hearing Loss in patient with Chronic Myelogenous Leukemia - A case study
by: Aremu Shuaib Kayode, et al.
Published: (2018)